← Back to Search

Cannabinoid

CBD Oil for Stress Related to COVID-19 (CBDOIL Trial)

Phase 2 & 3
Recruiting
Led By Michael J Telch, Ph.D.
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 5-follow-up
Awards & highlights

CBDOIL Trial Summary

This trial will compare the effects of CBD isolate, full-spectrum CBD oil, broad-spectrum CBD oil, and placebo oil on reducing stress caused by COVID-19.

Who is the study for?
Adults aged 18-70 with COVID-19 related stress, anxiety, depression, anger, substance use issues or sleep disturbances can join. They must be fluent in English, have internet at home and agree to only use study products for 6 weeks. Pregnant individuals or those with certain medical conditions like liver disease or on specific medications cannot participate.Check my eligibility
What is being tested?
The trial is testing the effects of three types of CBD oil (isolate, full spectrum, broad-spectrum) versus a placebo oil on emotional distress caused by COVID-19. Participants will receive one of these treatments randomly and their symptoms will be monitored.See study design
What are the potential side effects?
Potential side effects are not detailed here but could include reactions similar to known CBD responses such as fatigue, changes in appetite or mood swings. Allergic reactions may occur especially if sensitive to coconut oil used as a carrier.

CBDOIL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 5-follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 5-follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PROMIS Emotional Distress Index
Secondary outcome measures
COVID-19 Coping Self-Efficacy
PROMIS Alcohol Negative Consequences Scale
PROMIS Anger Scale
+4 more

CBDOIL Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Broad-Spectrum CBD oil 300 mg.Active Control1 Intervention
Nightly oral administration of 300 mg. of Broad-Spectrum CBD Oil for 28 consecutive days
Group II: Full-Spectrum CBD Oil 300 mg.Active Control1 Intervention
Nightly oral administration of 300 mg. of Full Spectrum CBD Oil for 28 consecutive days
Group III: CBD-Isolate 300 mg.Active Control1 Intervention
Nightly oral administration of 300 mg. of CBD-Isolate for 28 consecutive days
Group IV: Placebo OilPlacebo Group1 Intervention
Nightly oral administration of 300 mg. of Placebo Oil for 28 consecutive days

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
347 Previous Clinical Trials
80,112 Total Patients Enrolled
1 Trials studying Substance Abuse
417 Patients Enrolled for Substance Abuse
Way West WellnessUNKNOWN
SunFlora.IncUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Broad-Spectrum CBD Oil (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT04603781 — Phase 2 & 3
Substance Abuse Research Study Groups: Broad-Spectrum CBD oil 300 mg., Placebo Oil, Full-Spectrum CBD Oil 300 mg., CBD-Isolate 300 mg.
Substance Abuse Clinical Trial 2023: Broad-Spectrum CBD Oil Highlights & Side Effects. Trial Name: NCT04603781 — Phase 2 & 3
Broad-Spectrum CBD Oil (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04603781 — Phase 2 & 3
Substance Abuse Patient Testimony for trial: Trial Name: NCT04603781 — Phase 2 & 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients still being enrolled in this research project?

"Yes, as the clinicaltrials.gov website shows, this trial is still seeking patients. The listing was originally posted on December 4th, 2020 and was last edited on June 2nd, 2022."

Answered by AI

Can people of all ages participate in this research?

"This study includes all patients that fall within the age parameters of 18 to 70 years old."

Answered by AI

To whom does this research opportunity extend?

"This study is looking for 160 participants who currently suffer from anger. The patients must also meet the following criteria: Displays elevated symptom scores on one or more of the following established assessment instruments for depression (PROMIS-Depression), anxiety (PROMIS-Anxiety), Anger (PROMIS-Anger), sleep disturbance (PROMIS-Sleep); or Alcohol/Substance (PROMIS-Alcohol; PROMIS- Substance Use), Age between 18 to 70;, Fluent in English;, Has home access to the Internet;, Willingness to provide signed informed consent;"

Answered by AI

How many total people are allowed to join this clinical trial?

"That is accurate. According to the information available on clinicaltrials.gov, this study is still looking for patients. It was first posted on 2020-12-04 and was updated on 2022-06-02. The research team hopes to enroll 160 patients from 1 medical facility."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas at Austin, Laboratory for the Study of Anxiety Disorders
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
0

Why did patients apply to this trial?

I read the discription and I am very interested. i felt like it was a good fit. I want to help make symptoms better and explore other options.
PatientReceived no prior treatments
I've tried medication and I don't like the way they make me feel. I would like to try a more holistic approach.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

What is the pay out? How much is the payment? I can begin ASAP and my schedule is wide open.. when will it begin and is it a paid study?
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. University of Texas at Austin, Laboratory for the Study of Anxiety Disorders: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
~47 spots leftby Mar 2025